Confocal Imaging Through Thick Dermal Tissue (Phase II) - James Zavislan

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: National Cancer Institute (NCI)
Type: Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #: 5R44CA058054-03
Application #: 2098765
Study Section: Special Emphasis Panel (ZRG7-SSS-3 (10))

Project Start: 1992-08-01
Project End: 1998-04-30
Budget Start: 1996-09-01
Budget End: 1998-04-30
Support Year: 3
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: Lucid Technologies, Inc.
Department
Type
DUNS #

City: Henrietta
State: NY
Country: United States
Zip Code: 14467

Related projects


NIH 2008 R44 CA	Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis Eastman, Jay M. / Lucid, Inc.	$574,526
NIH 2007 R44 CA	Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis Eastman, Jay M. / Lucid, Inc.	$793,143
NIH 2006 R44 CA	Accuracy of In-vivo Confocal Imaging for Pigmented Lesion Diagnosis Eastman, Jay M. / Lucid, Inc.	$672,011
NIH 1996 R44 CA	Confocal Imaging Through Thick Dermal Tissue (Phase II) Zavislan, James M. / Lucid Technologies, Inc.
NIH 1995 R44 CA	Confocal Imaging Through Thick Dermal Tissue (Phase II) Zavislan, James M. / Lucid Technologies, Inc.

Publications

Hashemi, Pantea; Pulitzer, Melissa P; Scope, Alon et al. (2012) Langerhans cells and melanocytes share similar morphologic features under in vivo reflectance confocal microscopy: a challenge for melanoma diagnosis. J Am Acad Dermatol 66:452-62

Comments

Be the first to comment on James Zavislan's grant